Hyperkalemia: Therapeutic options in acute and chronic renal failure

Clinical Nephrology

Volumn 46, Issue 1, 1996, Pages 67-69

  Kemper, M J ^a   Harps, E ^a   Muller Wiefel D E ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Children; Hyperkalemia; Renal failure; Salbutamol; Treatment

Indexed keywords

FUROSEMIDE; GLUCOSE; INSULIN; POTASSIUM ION; SALBUTAMOL;

ACUTE KIDNEY FAILURE; ADOLESCENT; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE SEVERITY; HEART RATE; HUMAN; HYPERKALEMIA; INFANT; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC ACIDOSIS; POTASSIUM BLOOD LEVEL; POTASSIUM INTAKE; URINARY EXCRETION;

ACUTE DISEASE; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ALBUTEROL; CHILD; CHILD, PRESCHOOL; HUMANS; HYPERKALEMIA; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; POTASSIUM; TREATMENT OUTCOME;

EID: 0030004229     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Allon M 1993 Treatment and prevention of hyperkalemia in end-stage renal disease. Kidney Int 43: 1197-1209
2. Allon M, Copkney C 1990 Albuterol and insuline for treatment of hyperkalemia in hemodialysis patients. Kidney Int 38: 869-872
3. Blumberg A, Wiedmann P, Shaw S, Gnadinger M 1988 Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 85: 507-512
4. Blumberg A, Wiedmann P, Ferrari P 1992 Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int 41: 369-374
5. Brown MJ, Brown DC, Murphy MB 1983 Hypokalemia from β-2 receptor stimulation by circulating epinephrine. N Engl J Med 309: 1414-1419
6. Conte G, Dal Canton A, Imperatore P et al. 1990 Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. Kidney Int 38: 301-307
7. Flinn RB, Merill JP, Welzant WR 1961 Treatment of the oliguric patient with a new sodium-exchange resin and sorbitol: A preliminary report. N Engl J Med 264: 115-119
8. Hager SR 1989 Insuline-resistance of uremia. Am J Kid Dis 14: 272-276
9. Lens XM, Montoliu J, Cases A, Campistol JM, Revert L 1989 Treatment of hyperkalemia in renal failure: salbutamol vs. insuline. Nephrol Dial Transplant 4: 228-232
10. Liou H-H, Chiang S-S, Wu S-C, Huang T-P, Campese VM, Smorgorzewski M, Yang W-C 1994 Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Am J Kid Dis 23: 266-271
11. Murdoch I A, Dos Anjos R, Haycock G B 1991 Treatment of hyperkalemia with intravenous salbutamol. Arch Dis Child 66: 527-28
12. McClure RJ, Prasad VK, Brocklebank JT 1994 Treatment of hyperkalemia using intravenous and nebulised salbutamol. Arch Dis Child 70: 126-128
13. Papile LA, Burstein J, Burstein R, Koffler H, Koops B 1978 Relationship of intravenous sodium bicarbonate infusions and cerebral intraventricular hemorrhage. J Pediatr 93: 834-836
14. Poole-Wilson PA, Cameron IR 1975 Intracellular pH and K+ of cardiac and skeletal muscle in acidosis and alkalosis. Am J Physiol 229: 1305-1320
15. Wang P, Clausen T 1976 Treatment of attacks in hyperkalemic familial periodic paralysis by inhalation of salbutamol. Lancet i: 221-223